In 2012, the Journal of the American Medical Association (JAMA) published a criticism that study after study had been funded by NCCAM, but "failed to prove that complementary or alternative therapies are anything more than placebos".
I 2012 udgav Journal of the American Medical Association (JAMA) af at studie efter studie blev økonomisk støttet af NCCAM, men "fejlede i at bevise at komplementære eller alternative behandlinger er mere end blot placebo".